← All companies

Bristol-Myers Squibb Company (BMY)

Hold Current rating · 2 reports

2026-07-31

Hold Recap: Q2 2026

Eliquis Rewrites the 2026 Guide While Underlying EPS Sits Flat and Two Flagship Readouts Slip to 2027
2026-05-01

Hold Recap: Q1 2026

Growth Portfolio Clears Half of Revenue While EPS Falls 12%: Initiating Bristol Myers Squibb at Hold Ahead of a Binary Second Half